Shionogi & Co Ltd 2019 Integrated Report
The report highlights Shionogi's commitment to sustainable growth and healthcare access, particularly through its Mother to Mother SHIONOGI Project in Kenya and its initiatives to combat antimicrobial resistance (AMR). The company established Shionogi Pharma Co., Ltd. in October 2018 to integrate its manufacturing functions and enhance stable supply. Shionogi also declared its participation in the United Nations Global Compact in August 2019 and continues to align its activities with the Sustainable Development Goals, particularly SDG 3. Furthermore, the company has strengthened its corporate governance structure, including the appointment of independent outside directors and the implementation of a robust compliance framework.
Company: Shionogi & Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Integrated Report
Pages: 114
Shionogi & Co Ltd
The report highlights Shionogi's commitment to sustainable growth and healthcare access, particularly through its Mother to Mother SHIONOGI Project in Kenya and its initiatives to combat antimicrobial resistance (AMR). The company established Shionogi Pharma Co., Ltd. in October 2018 to integrate its manufacturing functions and enhance stable supply. Shionogi also declared its participation in the United Nations Global Compact in August 2019 and continues to align its activities with the Sustainable Development Goals, particularly SDG 3. Furthermore, the company has strengthened its corporate governance structure, including the appointment of independent outside directors and the implementation of a robust compliance framework.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2018
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management